Literature DB >> 1988525

Three new serovars of Chlamydia trachomatis: Da, Ia, and L2a.

S P Wang1, J T Grayston.   

Abstract

Three new Chlamydia trachomatis serovars were identified by several monoclonal antibodies in the microimmunofluorescence test and are proposed to be called Da, Ia, and L2a. Each was clearly distinguishable from the related serovars D, I, and L2. To date, 7, 41, and 4 isolates of the respective serovars have been identified. Each appears to be distributed worldwide. The findings meet previously established criteria for establishment of new serovars.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988525     DOI: 10.1093/infdis/163.2.403

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

2.  Comparison of immunotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining and radioimmunoassay.

Authors:  B J van der Pol; R B Jones
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots.

Authors:  João P Gomes; William J Bruno; Alexandra Nunes; Nicole Santos; Carlos Florindo; Maria J Borrego; Deborah Dean
Journal:  Genome Res       Date:  2006-11-07       Impact factor: 9.043

4.  Serotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining of inclusions in cell culture with monoclonal antibodies.

Authors:  S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

5.  Antigenic and molecular analyses of different Chlamydia pneumoniae strains.

Authors:  C A Jantos; S Heck; R Roggendorf; M Sen-Gupta; J H Hegemann
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

6.  Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease.

Authors:  D Dean; K Millman
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

7.  Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection.

Authors:  Norma Olivares-Zavaleta; William Whitmire; Donald Gardner; Harlan D Caldwell
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

8.  External quality assessment for detection of Chlamydia trachomatis.

Authors:  V J Chalker; H Vaughan; P Patel; A Rossouw; H Seyedzadeh; K Gerrard; V L A James
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Chlamydia trachomatis serovar differentiation by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene.

Authors:  E Poole; I Lamont
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Predicting phenotype and emerging strains among Chlamydia trachomatis infections.

Authors:  Deborah Dean; William J Bruno; Raymond Wan; João P Gomes; Stéphanie Devignot; Tigist Mehari; Henry J C de Vries; Servaas A Morré; Garry Myers; Timothy D Read; Brian G Spratt
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.